Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617692 · ClinicalTrials.gov registry record
Cannabis Use in Cancer Patients
A clinical trial of Solid Tumor, Adult, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 27
- Enrollment target
- 2
- Study locations
NCT03617692: Completed study of Solid Tumor, Adult, sponsored by University of Colorado, Denver.
NCT03617692 is a study of Solid Tumor, Adult that has completed, run by University of Colorado, Denver. The registered enrollment target is 27 participants, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03617692, a study of Solid Tumor, Adult, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
Primary Outcome
Enroll a minimum of 30 patients and demonstrate reasonable compliance with study procedures within 54 months of active recruiting.
Conditions Studied
Study Locations (2)
Colorado
- University of Colorado Hospital - Aurora
- University of Colorado Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2022-12-12 |
What the finished NCT03617692 record still lists
NCT03617692 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Solid Tumor, Adult appearing as the primary indexed condition, and to 0 interventions.
NCT03617692 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03617692 about?
NCT03617692 is a clinical study titled "Cannabis Use in Cancer Patients". The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
What is the current status of trial NCT03617692?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2018-12-04. Estimated completion is 2022-12-12.
What conditions does trial NCT03617692 study?
This clinical trial studies the following conditions: Solid Tumor, Adult.
Who is sponsoring clinical trial NCT03617692?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617692 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03617692's enrollment target sits among peer trials
27 69th of 72 higher than 4 of 72 other Solid Tumor, Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
RECRUITING
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
RECRUITING · NA
-
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI